Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2016-11-07 Regulatory Filings
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 7th, 2016, announcing a specific operational milestone: the first successful implantation and activation of the IRIS® II bionic vision system in the UK at Moorfields Eye Hospital. It details clinical trial progress, regulatory milestones (CE mark), and future development plans (PRIMA system). This type of announcement, focusing on a specific operational or clinical event rather than comprehensive periodic financial results (10-K, IR, ER) or management changes (MANG), is best classified as a general Regulatory Filing or Announcement, as it is a material event disclosure. Since it is not a standard financial report, a specific management change, or a dividend notice, and it is a formal announcement, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for material, non-standard disclosures. It is not an Earnings Release (ER) or an Interim Report (IR) as it contains no period-end financial statements.
2016-11-07 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 7, 2016, announcing a significant operational milestone: the successful implantation and activation of the first patient in the UK with the IRIS® II bionic vision system. It details the procedure, quotes the lead surgeon and the CEO, mentions ongoing clinical trials (multicenter European study), regulatory milestones (CE marking received in July 2016), and provides updates on another product (PRIMA). This content structure—a formal announcement of a specific corporate event, clinical progress, and regulatory status, issued via press release—is characteristic of a general corporate update or news release. Since it is not a full financial report (10-K, IR), a specific financial release (ER), a proxy statement (DEF 14A), or a dedicated management discussion (MDA), the most appropriate classification is the general regulatory/corporate announcement category, RNS (Regulatory Filings), as it serves as a broad communication of material, non-financial news to the market.
2016-11-07 French
Rapport financier semestriel 2016
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'RAPPORT FINANCIER SEMESTRIEL 2016' (Interim Financial Report 2016) and covers the period ending June 30, 2016. It contains comprehensive financial statements, including the Statement of Financial Position, Statement of Comprehensive Income, and Cash Flow Statement, as well as management discussion and audit information. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2016
2016-10-19 French
Interim Financial report 2016
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'INTERIM FINANCIAL REPORT 2016' and covers the semester ended June 30, 2016. It contains comprehensive financial statements, including the balance sheet, income statement, cash flow statement, and statement of changes in shareholder's equity, along with management discussion and auditor's notes. It is not an announcement or a summary, but the full interim report itself. H1 2016
2016-10-19 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Capital/Financing Update Classification · 99% confidence The document is an announcement titled "Pixium Vision annonce la signature d'un financement obligataire d'un montant de 11 millions d'euros". It details the issuance of a bond (emprunt obligataire) and warrants (bon de souscription d'actions) to Kreos Capital. This clearly relates to the company raising capital or changing its financing structure. Based on the provided definitions, the most appropriate category is 'Capital/Financing Update' (CAP). The document is a press release announcing a financial transaction, not a full annual report (10-K) or a general regulatory filing (RNS).
2016-09-29 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Capital/Financing Update Classification · 99% confidence The document is titled "Pixium Vision announces an 11 million Euros bond financing facility" and details the signature of a financing agreement involving the issuance of bonds and warrants to Kreos Capital. This content directly relates to the company raising capital and changing its financing structure. This aligns perfectly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it describes a specific corporate finance event.
2016-09-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.